Fact Sheet: Common Carp Pituitary INAD 8391

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:
CCP

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet
(MSDS)

Study Summaries

What's the status of this drug's
approval

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of CCP to induce gamete maturation in a variety of fish species.
Drug name: Common Carp Pituitary (CCP)
Source of drug: Stoller Fisheries Argent Laboratories
Address: 1301 18th St; PO Box B
Spirit Lake, IA 51360
8702 152nd Avenue, N.E. Redmond, WA 98052
Contact:

Phone: 800-831-5174
email: stollerfisheries@mchsi.com
webpage: http://www.sfishinc.com/

Phone: 800-426-6258
email: email@argent-labs.com
webpage: http://www.argent-labs.com/
Target pathogen(s): Not Applicable
Method of administration: IP or IM injection
Treatment dosage:

up to 25 milligrams (mg) CCP per kilogram (kg) body weight.

Although certain situations may require a higher dose rate, dosage should never exceed 25 mg CCP per kg body weight

Treatment regimen:

Single or multiple treatment. Multiple treatment will generally consist of a single "priming dose," followed by a single "resolving dose."

Withdrawal period:

No withdrawal period is required for treated fish.

Required test parameters: Investigator must collect data reporting percent ovulation and/or percent spermiation in treated fish. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 8391 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.

Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.